Efficacy and safety of Picibanil (OK-432) for pleurodesis in refractory pneumothorax and postoperative lung fistula

Trial Profile

Efficacy and safety of Picibanil (OK-432) for pleurodesis in refractory pneumothorax and postoperative lung fistula

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Feb 2018

At a glance

  • Drugs Picibanil (Primary)
  • Indications Postoperative complications
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top